Growth Metrics

Amneal Pharmaceuticals (AMRX) Goodwill & Intangibles (2017 - 2025)

Historic Goodwill & Intangibles for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to $1.2 billion.

  • Amneal Pharmaceuticals' Goodwill & Intangibles fell 1411.88% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year decrease of 1411.88%. This contributed to the annual value of $1.3 billion for FY2024, which is 1069.4% down from last year.
  • Amneal Pharmaceuticals' Goodwill & Intangibles amounted to $1.2 billion in Q3 2025, which was down 1411.88% from $1.2 billion recorded in Q2 2025.
  • Over the past 5 years, Amneal Pharmaceuticals' Goodwill & Intangibles peaked at $1.8 billion during Q2 2021, and registered a low of $1.2 billion during Q3 2025.
  • Its 5-year average for Goodwill & Intangibles is $1.6 billion, with a median of $1.6 billion in 2023.
  • In the last 5 years, Amneal Pharmaceuticals' Goodwill & Intangibles crashed by 1982.91% in 2021 and then surged by 151.19% in 2022.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Goodwill & Intangibles stood at $1.8 billion in 2021, then dropped by 3.69% to $1.7 billion in 2022, then fell by 12.15% to $1.5 billion in 2023, then fell by 10.69% to $1.3 billion in 2024, then dropped by 10.97% to $1.2 billion in 2025.
  • Its Goodwill & Intangibles stands at $1.2 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.3 billion for Q1 2025.